Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
US Army
Julphar
Queensland Health
Boehringer Ingelheim
Chinese Patent Office
Medtronic
Accenture

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018405

« Back to Dashboard

NDA 018405 describes AYGESTIN, which is a drug marketed by Duramed Res and is included in one NDA. Additional details are available on the AYGESTIN profile page.

The generic ingredient in AYGESTIN is norethindrone acetate. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the norethindrone acetate profile page.
Summary for 018405
Tradename:AYGESTIN
Applicant:Duramed Res
Ingredient:norethindrone acetate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG
Approval Date:Apr 21, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Healthtrust
Farmers Insurance
Daiichi Sankyo
McKesson
Federal Trade Commission
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.